Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-α

Anti-Cancer Drugs

Volumn 8, Issue 1, 1997, Pages 80-87

  Seong, Jinsil ^a   Milross, Christopher G ^b   Hunter, Nancy R ^d   Shin, Hang C ^c   Milas, Luka ^d  

^a Yonsei University College of Medicine   (South Korea)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c Hanhyo Institute of Technology   (South Korea)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

apoptosis; murine tumors; paclitaxel; tumor necrosis factor

Indexed keywords

PACLITAXEL; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER GRAFT; CONTROLLED STUDY; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA; CARCINOMA, HEPATOCELLULAR; DRUG SYNERGISM; FEMALE; LIVER NEOPLASMS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; MITOSIS; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; PACLITAXEL; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031055545     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199701000-00011     Document Type: Article

References (46)

1. Old LJ. Tumor necrosis factor. Science 1985; 230: 630-4.
2. Sugarman BJ, Aggarwal BB, Haas PE, et al. Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 1985; 230: 943-5.
3. Carswell EA, Old LJ, Kassel RL, et al. An endotoxin induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666-70.
4. Pennica D, Nedwin GE, Hayflick JS, et al. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984; 312: 724-9.
5. Urban JL, Shepard HM, Rothstein JL, et al. Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages. Proc Natl Acad Sci USA 1986; 83; 5233-7.
6. Feinman R, Henriksen-DeStefano D, Tsujimoto M, et al. Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. J Immunol 1987; 138: 635-40.
7. Sato N, Goto T, Haranaka K, et al. Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. J Natl Cancer Inst 1985; 76: 1113-21.
8. Gamble JR, Harlan JM, Klebanoff SL, et al. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 1985; 82: 8667-71.
9. Cavender D, Saegusa Y, Ziff M. Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. J Immunol 1987; 139: 1855-60.
10. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163: 740-5.
11. Darzynkiewicz Z, Williamson B, Carswell EA, et al. Cell cycle-specific effects of tumor necrosis factor. Cancer Res 1984; 44: 83-90.
12. Khan A, Pichyankul S. Potentiation of antitumor effect of lymphotoxin by antitumor drugs and elevated temperature. Proc Am Ass Cancer Res 1985; 26: 304.
13. Alexander RB, Nelson WG, Coffey DS. Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II. Cancer Res 1987; 47: 2403-6.
14. Alexander RB, Isaacs JT, Coffey DS. Tumor necrosis factor enhances the in vitro and in vivo efficacy of chemotherapeutic drugs targeted at DNA topoisomerase II in the treatment of murine bladder cancer. J Urol 1987; 138: 427-9.
15. Hallahan DE, Spriggs DR, Beckett MA, et al. Increased tumor necrosis factor mRNA following ionizing radiation exposure. Proc Natl Acad Sci USA 1989; 86: 10104-7.
16. Manneta A, Lucci J, Soopikian J, et al. In vitro cytotoxicity of human recombinant tumor necrosis factor α in association with radiotherapy in a human ovarian cancer cell line, Gynecol Oncol 1990; 38: 200-2.
17. Sersa G, Willingham V, Milas L. Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy, Int J Cancer 1988; 42: 129-34.
18. Nishiguchi I, Willingham V, Milas L. Tumor necrosis factor as an adjunct to fractionated radiotherapy in the treatment of murine tumors, Int J Radiat Oncol Biol Phys 1990; 18: 555-8.
19. Bowman RV, Whitaker D, Manning LS, et al. Interaction between dactinomycin and tumor necrosis factor in mesothelioma. Cancer 1991; 67: 2495-500.
20. Huang P, Allam A, Perez L, et al. The effect of combining recombinant human tumor necrosis factor-alpha with local radiation on tumor control probability of a human glioblastoma multiforme xenograft in nude mice, Int J Radiat Oncol Biol Phys 1995; 32: 93-8.
21. Yamauchi N, Karizana H, Watanabe H, et al. Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor. Cancer Res 1989; 49: 1671-5.
22. Zimmerman RJ, Chan A, Leadon SA. Oxidative damage in murine tumor cells treated in vitro by human TNE Cancer Res 1989; 49: 1644-8.
23. Weichselbaum RR, Hallahan DE, Beckett MA, et al. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res 1994; 54: 4266-9.
24. Rose WC. Taxol: a review of its preclinical in vivo antitumor activity. Anticancer Drugs 1992; 3: 311-21.
25. Milross CG, Mason KA, Hunter NR, et al. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst 1996; 88: 1308-14.
26. Rowinsky EK, Onetto N, Canetta RM, et al. Taxol: the first of the taxanes, an important new class of antitumor agents. Semin Oncol 1992; 19: 134-6.
27. Ajani JA, Ilson DH, Daugherty K, et al. Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 1994; 86: 1086-91.
28. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979; 277: 665-7.
29. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 1980; 77: 1561-5.
30. Bhalla K, Ibrado AM, Tourkina E, et al. Taxol induces intranucleosomal fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 1993; 7: 563-8.
31. Milas L, Hunter NR, Kurdoglu B, et al. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with Taxol (paclitaxel). Cancer Chemother Pharmacol 1995; 35: 297-303.
32. Ding AH, Porteu F, Sanchez E, et al. Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 1990; 247: 370.
33. Burkhardt CA, Berman JW, Swindell CS, et al. Relationship between the structure of taxol and other taxanes on induction of tumor necrosis factor-α gene expression and cytotoxicity. Cancer Res 1994; 54: 5779-82.
34. Milas L, Hunter NR, Mason KA, et al. Immunological resistance to pulmonary metastases in C3Hf/Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res 1974; 34: 61-71.
35. Shin N, Lee I, Jang S, et al. Development of novel human tumor necrosis factor-alpha muteins. Proc BPERC Int Symp 1994; 43-50.
36. Elias E, Moore PB, Rose SM. Tumor necrosis factor induced DNA fragmentation of HL-60 cells. Biochem Biophys Res Commun 1988; 157: 963-9.
37. Greenblatt MS, Elias L. The type B receptor for tumor necrosis factor-α mediates DNA fragmentation in HL-60 and U937 cells and differentiation in HL-60 cells. Blood 1992; 80: 1339-46.
38. Fesel K, Kolb-Bachofen V, Kolb H. Analysis of TNF-α induced strand breaks at the single cell level. Am J Pathol 1991; 139: 251-4.
39. Isogai E, Isogai H, Kimura K, et al. In vivo induction of apoptosis and immune response in mice by administration of lipopolysaccharide from Porphyromonas gingivalis. Infect Immun 1996; 64: 1461-6.
40. Leist M, Gantner F, Bohlinger I, et al. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995; 146: 1220-34.
41. Bogden C, Ding A. Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor α and interleukin-1 in macrophages. J Leukocyte Biol 1992; 52: 119-21.
42. Allen JN, Moore SA, Wewers MD. Taxol enhances but does not induce interleukin-1β and tumor necrosis factor-α production. J Lab Clin Med 1993; 122: 374-81.
43. Allen JN, Herzyk DJ, Wewers MD. Colchicine has opposite effects on interleukin-1β and tumor necrosis factor-α production. Am J Physiol Lung Cell Mol Physiol 1991; 261: 315-21.
44. d, macrophages. Mol Med 1995; 1: 428-35.
45. Bilej M, Sima P, Hofman J, et al. Changes in the arrangement of the microtubule system of murine peritoneal cells after an antigenic stimulation. Cell Biol Int Rep 1987; 11: 717-22.
46. Ding A, Sanchez E, Tancinco M, et al. Interaction of bacterial lipopolysaccharide with microtubule proteins. J Immunol 1992; 148: 2853-8.